Cliniques Universitaires St-Luc — Brussels

Public research footprint of Cliniques Universitaires St-Luc, compiled from the ClinicalTrials.gov public registry.

211

Registered studies

Active

Recruiting now

125

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Non-Small Cell Lung Cancer · Ovarian Cancer · Moderately to Severely Active Crohns Disease

Recently updated registry entries

NCT02486718 — Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best… (Active Not Recruiting)
NCT03075696 — A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination… (Active Not Recruiting)
NCT05460000 — A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Cliniques Universitaires St-Luc?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.